Copper that cancer with lysosomal love! (Editorial)

Loading...
Thumbnail Image
File version

Version of Record (VoR)

Author(s)
Kovacevic, Zaklina
Sahni, Sumit
Richardson, Des R
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2016
Size
File type(s)
Location
Abstract

There is now extensive evidence that chelation of copper and/or iron can inhibit tumour growth in cell culture, animal models and human clinical trials. These effects are due to the essential role these metal ions play in a variety of biological processes, including DNA synthesis. As such, there is growing interest in the development of new agents that surpass the anti-tumor activity of traditional metal-binding drugs such as desferrioxamine (DFO)

Journal Title

Aging-US

Conference Title
Book Title
Edition
Volume

8

Issue

2

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© The Author(s) 2016. This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Item Access Status
Note
Access the data
Related item(s)
Subject

Biochemistry and cell biology

Zoology

Oncology and carcinogenesis

Science & Technology

Life Sciences & Biomedicine

Geriatrics & Gerontology

Dp44mT

Persistent link to this record
Citation

Kovacevic, Z; Sahni, S; Richardson, DR, Copper that cancer with lysosomal love! (Editorial), Aging-US, 2016, 8 (2), pp. 210-211

Collections